
Vtv Therapeutics To Participate In Upcoming September Investor Conferences
H.C. Wainwright 27th Annual Global Investment Conference | |
Date: | Tuesday, September 9, 2025 |
Format: | 1x1 Investor Meetings Only |
Morgan Stanley 23rd Annual Global Healthcare Conference | |
Date: | Tuesday, September 9, 2025 |
Format: | Fireside Chat Time: 2:35 PM - 3:10 PM EST and 1x1 Investor Meetings |
About vTv Therapeutics
vTv Therapeutics is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. vTv's clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential first-in-class oral glucokinase activator being investigated for the treatment of type 1 diabetes. vTv and its development partners are investigating multiple molecules across different indications for chronic diseases. Learn more at vtvtherapeutics.com or follow the company on LinkedIn or X .
Investor Contact
John Fraunces
LifeSci Advisors, LLC
...
Media Contact
Caren Begun
TellMed Strategies
201-396-8551
...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- R0AR Chain Announces $100,000 Community Rewards For Creators, Yappers, And Brand Evangelists
- Cryptolists Recognised As“Crypto Affiliate Of The Year” At SBC's Affiliate Leaders Awards 2025
- Tradesta Becomes The First Perpetuals Exchange To Launch Equities On Avalanche
- 0G Labs Launches Aristotle Mainnet With Largest Day-One Ecosystem For Decentralized AI
- Nebeus Overfunds Equity Crowdfunding Campaign With €3.6M Raised, Reflecting Growing Demand For Regulated Cryptofinance Solutions
- Daytrading Publishes New Study Showing 70% Of Viral Finance Tiktoks Are Misleading
Comments
No comment